-
Metformin could Reduce Risk of Basal Cell Carcinoma:
A new study shows that Metformin, a commonly used diabetes medication, can possibly reduce the risk of basal cell carcinoma via its chemoprotective effect. Metformin has some anticarcinogenic properties that Read moreCategory: Prevention Topics,  Skin Cancer